SHREE GANESH REMEDIES LIMITED

Scale -

Revenue is 109 Rs Cr; 5 Year CAGR is 33 %; in Bottom Quartile
Ebitda is 38.04 Rs Cr; 5 Year CAGR is 40 %; Continuous Decline over 3 years; in Bottom Quartile
PBT is 1.53 Rs Cr; 5 Year CAGR is 29 %; Annual Decline is -23 %
PAT is 17.76 Rs Cr; 5 Year CAGR is 30 %; Annual Decline is -23 %; Continuous Decline over 3 years

Quarterly Revenue is 14.36 Rs Cr; in Bottom Quartile

Profitability -

PBDIT Margin is 34.81 %; in Top Quartile
PAT Margin is 16.25 %; in Top Quartile; Annual Decline is -23 %; Continuous Decline over 3 years

Return -

ROA is 8.55 %; in Top Quartile; Annual Decline is -29 %; Continuous Decline over 3 years

ROCE is 14.82 %; Annual Decline is -22 %; Continuous Decline over 3 years
ROE is 10.89 %; Annual Decline is -31 %; Continuous Decline over 3 years
Asset Turnover is 55 %; 5 Year CAGR is -72 %

Efficiency -

Inventory Turnover Ratio is 4.75; Continuous Growth over 3 years
Current Ratio is 3.96; in Top Quartile
Quick Ratio is 2.85; in Top Quartile

Solvancy -

Contingent Liabilities is 1.66 Rs Cr; Annual Decline is -68 %
Debt/Equity is 0.19; Continuous Decline over 3 years; 5 Year CAGR is 76 %

Long term Debt is 21.25 Rs Cr; 5 Year CAGR is 207 %
Total Debt is 30.67 Rs Cr; 5 Year CAGR is 171 %

Quality -

Operating cashflow/PAT is 134 %; Continuous Growth over 3 years

Change in Inventories/Total Expenses is 1 %; Annual Growth is 158 %; Continuous Growth over 3 years; in Top Quartile
Exceptional Items/PBT is 0 %; in Top Quartile

Quarterly Results- overall

Annual Results- Scale

Annual Results- Liquidity

Annual Results- Profitability/Return

Annual Results- Valuation

External Ecosystem

Sector

Major Subsidiaries/Associates

Key Clients

Products

Products

Product details

Operations

Capacity/ Production

Key Facilities

Key Certifications

Raw materials

Search: